Effective as of August 31st 2016
Spectrum Medical Ltd and Medtronic Inc. have entered into a strategic and
exclusive relationship for the distribution of Spectrum Medical’s new Quantum
Perfusion Systems. The initial three
year term includes all markets in Europe, Africa, The Middle East, Central
Asia, Canada, Australia and New Zealand.
Following five years of intensive Research
and Development Spectrum Medical will launch in 2017 an exciting new generation
of Extracorporeal Technologies and Integrated Patient Safety Systems designed
specifically for cardiopulmonary bypass and ECMO therapies.